Canakinumab (ACZ885) Vs. Triamcinolone Acetonide for Treatment of Acute Flares and Prevention of Recurrent Flares in Gouty Arthritis Patients Refractory to or Contraindicated to NSAIDs and/or Colchicine.

¹CHU Vaudois, University of Lausanne, Lausanne, Switzerland, ²Gozee, Belgium, ³Heartland Clinical Research, Omaha, NE, ⁴Moscow State University of Medicine and Dentistry, Moscow, Russia, ⁵Baskent University, Ankara, Turkey, ⁶Novartis Pharma AG, Basel, Switzerland, ⁷UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ